Feedback
Settings

Settings

Goto Application

420,345 results
Offices all Languages en Stemming true Single Family Member false Include NPL false
RSS feed can only be generated if you have a WIPO account

Save query

A private query is only visible to you when you are logged-in and can not be used in RSS feeds

Query Tree

Refine Options

Offices
All
Specify the language of your search keywords
Stemming reduces inflected words to their stem or root form.
For example the words fishing, fished,fish, and fisher are reduced to the root word,fish,
so a search for fisher returns all the different variations
Returns only one member of a family of patents
Include Non-Patent literature in results

Full Query

IC:A61K36/00

Side-by-side view shortcuts

General
Go to Search input
CTRL + SHIFT +
Go to Results (selected record)
CTRL + SHIFT +
Go to Detail (selected tab)
CTRL + SHIFT +
Go to Next page
CTRL +
Go to Previous page
CTRL +
Results (First, do 'Go to Results')
Go to Next record / image
/
Go to Previous record / image
/
Scroll Up
Page Up
Scroll Down
Page Down
Scroll to Top
CTRL + Home
Scroll to Bottom
CTRL + End
Detail (First, do 'Go to Detail')
Go to Next tab
Go to Previous tab

Analysis

1 / 42,035
1.WO/2024/084322PHARMACEUTICAL COMPOSITION COMPRISING HIGH PAY LOAD GINGER EXTRACT GRANULES AND PROCESS FOR PREPARATION THEREOF
WO - 25.04.2024
Int.Class A61K 36/9068
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
36Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
18Magnoliophyta (angiosperms)
88Liliopsida (monocotyledons)
906Zingiberaceae (Ginger family)
9068Zingiber, e.g. garden ginger
 Appl.No PCT/IB2023/060003 Applicant INDIA GLYCOLS LIMITED Inventor MAHANTA, Baidyanath
The present invention relates to a sustained release pharmaceutical composition comprising ginger extract. Particularly, this invention relates to sustained release granules of ginger extract wherein the ginger extract contains high payload of gingerols and shogaol. More particularly, the present invention relates to a sustained release granules of ginger extract wherein the granules release the gingerol and shogaols in sustained release manner. The present invention further relates to the process of preparation of ginger extract from ginger rhizome using supercritical fluid extraction wherein the extract is having high payload of gingerols and shogaol.
2.WO/2024/083827COMBINATION OF PSYLLIUM, BAOBAB AND ACACIA FOR THE PREVENTION AND TREATMENT OF CONSTIPATION OR DIGESTIVE DISORDERS
WO - 25.04.2024
Int.Class A61K 36/68
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
36Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
18Magnoliophyta (angiosperms)
185Magnoliopsida (dicotyledons)
68Plantaginaceae (Plantain Family)
 Appl.No PCT/EP2023/078835 Applicant URGO RECHERCHE INNOVATION ET DEVELOPPEMENT Inventor GUY, Martine
The present invention relates to a combination product comprising, as active substances, at least psyllium, baobab and acacia, for preventing and/or treating constipation or digestive disorders.
3.WO/2024/082325METHOD FOR EXTRACTING HIGH CONTENT OF NOTOGINSENOSIDE R1 FROM NOTOGINSENG RADIX ET RHIZOMA
WO - 25.04.2024
Int.Class G01N 30/90
GPHYSICS
01MEASURING; TESTING
NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
30Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography
90Plate chromatography, e.g. thin layer or paper chromatography
 Appl.No PCT/CN2022/127639 Applicant HUNAN XIANG MIN PHARMACEUTICAL CO., LTD Inventor WU, Xinming
A method for extracting a high content of notoginsenoside R1 from Notoginseng radix et rhizoma, which method belongs to the field of extraction of natural medicinal ingredients. The method comprises the following steps: (1) pretreatment, (2) steam treatment, (3) primary enzymolysis, (4) secondary enzymolysis, (5) evaporation and drying, (6) ethanol extraction, (7) treatment with macroporous resin, and (8) treatment with reverse chromatography. The method uses steam treatment to make a large amount of organic matter precipitate from cellulose, then uses bio-enzyme-based enzymolysis technology twice, and uses different bio-enzymes for stepwise degradation each time, so that an enzymolysis effect is improved, the content of effective ingredients in an extract solution is increased, the use of a large amount of organic solvents is avoided, the method is green and environmentally friendly, extraction is convenient, a 70% yield and 99% purity of notoginsenoside R1 are achieved, further purification treatment can be avoided, and notoginsenoside R1 can be directly used as an additive for medicines and health products.
4.WO/2024/084290COMPOSITION FOR USE IN A METHOD FOR THE PREVENTION AND TREATMENT OF COGNITIVE DECLINE AND/OR FORMS OF DEMENTIA
WO - 25.04.2024
Int.Class A61K 36/63
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
36Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
18Magnoliophyta (angiosperms)
185Magnoliopsida (dicotyledons)
63Oleaceae (Olive family), e.g. jasmine, lilac or ash tree
 Appl.No PCT/IB2023/053342 Applicant KOLINPHARMA S.P.A. Inventor PETRELLI, Rita Paola
It is an object of he present invention a composition and a formulation containing said composition and, optionally, additives or excipients or carriers of acceptable food or pharmaceutical grade. Further, the present invention relates to a composition and a formulation containing said composition and, optionally, additives or excipients or carriers of acceptable food or pharmaceutical grade for use in method for the prevention and/or treatment of cognitive decline and/or forms of dementia. It is an object of the present invention a composition for use in a method for the prevention and treatment of cognitive decline and/or forms of dementia, particularly a composition to counteract inflammation, oxidative stress, and cerebrovascular damage at the level of the central nervous system as causes of neurodegeneration leading to the onset of cognitive decline and development of dementia.
5.WO/2024/085700COMPOSITION FOR AMELIORATING, PREVENTING, OR TREATING MYOCARDIAL DAMAGE, CONTAINING CIRSIUM SETIDENS, CAPSELLA, OR SAURURUS CHINENSIS EXTRACT
WO - 25.04.2024
Int.Class A23L 33/105
AHUMAN NECESSITIES
23FOODS OR FOODSTUFFS; THEIR TREATMENT, NOT COVERED BY OTHER CLASSES
LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D91; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
33Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
10using additives
105Plant extracts, their artificial duplicates or their derivatives
 Appl.No PCT/KR2023/016305 Applicant KOREA FOOD RESEARCH INSTITUTE Inventor CHOI, Hyo Kyoung
The present invention relates to a composition for ameliorating, preventing, or treating myocardial damage caused by cardiotoxic drugs. The composition contains at least one selected from the group consisting of a Cirsium setidens extract, a Capsella extract, and a Saurus chinensis extract as an active ingredient, and thus can ameliorate, prevent, or treat myocardial damage caused by cardiotoxic drugs. In addition, the composition has no toxicity and thus can be taken in the form of a food.
6.WO/2024/086240BETA-ADRENERGIC AGONIST AND MUSCARINIC ANTAGONIST COMPOSITIONS AND METHODS OF USING
WO - 25.04.2024
Int.Class A61P 13/10
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
13Drugs for disorders of the urinary system
10of the bladder
 Appl.No PCT/US2023/035433 Applicant BONAFIDE HEALTH, LLC Inventor KOMOROWSKI, James R.
Disclosed herein are compositions for supporting bladder health and/or treating, ameliorating, preventing, or reducing overactive bladder or the symptoms associated therewith. The compositions disclosed herein comprise a beta-adrenergic receptor agonist and at least one muscarinic receptor antagonist. Also described herein are methods utilizing the aforementioned compositions.
7.WO/2024/082330METHOD FOR EXTRACTING RESINA DRACONIS
WO - 25.04.2024
Int.Class A61K 36/896
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
36Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
18Magnoliophyta (angiosperms)
88Liliopsida (monocotyledons)
896Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
 Appl.No PCT/CN2022/127872 Applicant HUNAN XIANG MIN PHARMACEUTICAL CO., LTD Inventor WU, Xinming
A method for extracting Resina draconis, which belongs to the field of extraction of natural plant ingredients. The method comprises the following steps: 1) pretreatment, 2) leaching and impurity removal, 3) supercritical extraction, 4) alkali extraction, 5) rotary evaporation, 6) vacuum drying, 7) pre-freezing, 8) freeze-drying and 9) vacuum packaging. Compared with the prior art, the method for extracting Resina draconis has the advantages that the amount used of an organic solvent is small, extraction conditions are mild, more natural ingredients are retained, and the content of impurities in an obtained extract is low. Moreover, a Resina draconis extract obtained by means of the extraction method also has a good effect with regard to treating allergic rhinitis, and can be used as an active ingredient to be added to traditional antiallergic drugs to play a synergistic effect, and the extract is a pure natural substance with few toxic and side effects.
8.WO/2024/085105ANTI-INFLAMMATORY AGENT, TNF-α PRODUCTION INHIBITOR, INTERLEUKIN-10 PRODUCTION PROMOTOR, SKIN EXTERNAL APPLICATION COMPOSITION, FOOD OR BEVERAGE COMPOSITION, METHOD FOR PREVENTING, AMELIORATING, OR TREATING INFLAMMATORY DISEASES, AND USE OF PLANT-DERIVED POLYAMINE-CONTAINING EXTRACT FOR MANUFACTURING ANTI-INFLAMMATORY AGENT
WO - 25.04.2024
Int.Class A61K 36/48
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
36Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
18Magnoliophyta (angiosperms)
185Magnoliopsida (dicotyledons)
48Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
 Appl.No PCT/JP2023/037358 Applicant TOYOBO CO., LTD. Inventor TOYAMA,Kinuka
A purpose of the present invention is to provide an anti-inflammatory agent, a TNF-α production inhibitor, and an IL-10 production promotor which contain a plant-derived active ingredient. Another purpose of the present invention is to provide a food or beverage composition and a skin external application composition which contain a plant-derived active ingredient and which have an anti-inflammatory effect. The anti-inflammatory agent, the TNF-α production inhibitor, and the IL-10 production promotor contain a plant-derived polyamine-containing extract. The plant-derived polyamine-containing extract includes a less-than-1 kDa fraction. The less-than-1 kDa fraction contains an active ingredient. The food or beverage composition and the skin external application composition contain the anti-inflammatory agent.
9.WO/2024/085750PREVENTION OF TREE NUT AND SEED ALLERGY IN HUMANS
WO - 25.04.2024
Int.Class A61K 36/185
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
36Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
18Magnoliophyta (angiosperms)
185Magnoliopsida (dicotyledons)
 Appl.No PCT/NL2023/050534 Applicant VINI MINI B.V. Inventor LANCEE, Laurie
The present invention relates to a composition for use in the prevention, reduction and/or treatment of tree nut and seed allergy in humans. Furthermore, the invention provides methods for prevention, reduction and/or treatment of tree nut and seed allergy in humans. The composition is administered in a series of 3 to 6 dose increment steps from an initial dose to a maximum dose and can be continued with a weekly dose for a time period of 3 to 12 months.
10.WO/2024/082014COMPOSITIONS COMPRISING CANNABIDIOLIC ACID AND FATTY ACIDS
WO - 25.04.2024
Int.Class A61K 36/185
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
36Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
18Magnoliophyta (angiosperms)
185Magnoliopsida (dicotyledons)
 Appl.No PCT/AU2023/051032 Applicant DOLCE CANN GLOBAL PTY LTD Inventor CALABRIA, Patrick Steve
The present invention relates to compositions comprising cannabidiolic acid and fatty acids; pharmaceuticals, nutraceuticals, medical foods, dietary supplements, functional foods, animal foods and dosage forms comprising this composition, processes for extracting this composition from cannabis and products produced by this process; and methods and uses thereof.
# -